Global Transplant Diagnostics Market Growth, Trends, and Key Players 2025-2033

Explore the global transplant diagnostics market projected to reach USD 11.90 billion by 2033, driven by chronic diseases, technological advancements, and innovative organ transplantation solutions.

Global Transplant Diagnostics Market Growth, Trends, and Key Players 2025-2033

Organ transplantation is a life-saving procedure that replaces a failing organ with a healthy one from a donor. The transplant diagnostics market plays a crucial role in ensuring compatibility between donors and recipients through Human Leukocyte Antigens (HLA) testing, performed via molecular and non-molecular assays. The global transplant diagnostics market size was valued at USD 6.26 billion in 2024 and is expected to reach USD 11.90 billion by 2033, growing at a CAGR of 7.4% from 2025 to 2033.

📥 Download Sample

Rising Demand Driven by Chronic Diseases

The increasing prevalence of chronic diseases is escalating organ failure cases worldwide, boosting the demand for organ transplants. Over 1 million tissue transplants are performed annually. In the U.S., around 133 million people suffered from chronic diseases in 2019, projected to reach 157 million by 2020. Chronic kidney disease (CKD) alone affects 37 million Americans, with 661,000 suffering from kidney failure and 193,000 living with a kidney transplant. This growing demand highlights the need for advanced transplant diagnostics.

Technological Advancements Fuel Market Growth

The gap between organ demand and supply is narrowing with innovations like personalized immunosuppressant drugs, 3D bioprinting, and stem cell–derived organs. Technologies such as nucleic acid amplification, genomic analysis, proteomics, and metabolomics are enabling cutting-edge molecular diagnostics. Additionally, the TransMedics Organ Care System keeps organs viable outside the body, reducing transplant waiting lists and improving outcomes.

Regional Insights: North America Leads the Market

North America, particularly the U.S. and Canada, dominates due to robust healthcare infrastructure, government support, and awareness initiatives by players like Roche collaborating with organizations such as the American Transplant Foundation and Donate Life America. With over 114,000 people on the U.S. transplant waiting list, the region remains a hotspot for transplant diagnostics research and innovation.

Market Segmentation

By Technology: Molecular Assays, Non-Molecular Assays
By Component: Instruments & Equipment, Reagents & Consumables, Software & Services
By Transplant: Kidney, Liver, Heart, Lung, Pancreas, Stem Cell, Soft Tissue, Bone Marrow
By End-Use: Hospitals & Transplant Centers, Research Labs, Standard Reference Labs

Key Players in Transplant Diagnostics Market

Abbott Laboratories, Biomérieux SA, F Hoffmann La Roche, Qiagen, ThermoFisher Scientific, Bio-Rad Laboratories, Immucor Inc., CareDx, Becton Dickinson, GenDx, Affymetrix, Immucor Transplant Diagnostics are among the prominent market leaders shaping innovation and expanding access to organ transplant solutions.

COVID-19 Impact

Organ donation faced challenges during the pandemic as transplant recipients are immunocompromised. Protective screening measures were introduced, and donors diagnosed with COVID-19 were asked to postpone donation for 14–28 days. Despite challenges, the market is steadily recovering with improved protocols and patient care strategies.

Recent Developments

  • In March 2020, CareDx, Inc. launched KIRA Immuno-Optimization for personalized transplant care.

  • In June 2019, Eurofins Scientific acquired Transplant Genomics Inc., advancing non-invasive genomics-based transplant monitoring.

The transplant diagnostics market continues to evolve rapidly with innovations, rising awareness, and the urgent need to address organ shortages worldwide.

About Us:
Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:
Email: [email protected]
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/